Charles Haaser
Director of Finance/CFO bij YIELD10 BIOSCIENCE, INC.
Vermogen: 53 527 $ op 31-03-2024
Profiel
Charles B.
Haaser's career history includes current and former positions as well as education.
Currently, he is the Chief Accounting Officer, Treasurer & VP-Finance at Yield10.
Bioscience, Inc. He started this position in 2016.
Previously, he worked as the Finance Director at ISI Systems, Inc. from 1986 to 1997.
From 1998 to 2006, he served as the Controller, Chief Accounting & Financial Officer at ABIOMED, Inc. Following that, he was the Corporate Controller at Indevus Pharmaceuticals, Inc. from 2006 to 2008.
Additionally, he worked as the Controller at Technical Communications Corp.
from 1986 to 1998.
Mr. Haaser also has experience as an Auditor at PricewaterhouseCoopers LLP.
In terms of education, he completed his undergraduate degree at the University of Notre Dame, his graduate degree at Bentley University, and his MBA at Northeastern University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
YIELD10 BIOSCIENCE, INC.
1.18% | 15-02-2024 | 140 861 ( 1.18% ) | 53 527 $ | 31-03-2024 |
Actieve functies van Charles Haaser
| Bedrijven | Functie | Begin |
|---|---|---|
| YIELD10 BIOSCIENCE, INC. | Director of Finance/CFO | 03-11-2014 |
Eerdere bekende functies van Charles Haaser
| Bedrijven | Functie | Einde |
|---|---|---|
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Comptroller/Controller/Auditor | 01-01-2008 |
| ABIOMED, INC. | Director of Finance/CFO | 30-05-2006 |
| TECHNICAL COMMUNICATIONS CORPORATION | Comptroller/Controller/Auditor | 01-01-1998 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | - |
Opleiding van Charles Haaser
| University of Notre Dame | Undergraduate Degree |
| Northeastern University | Masters Business Admin |
| Bentley University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TECHNICAL COMMUNICATIONS CORPORATION | Industrial Services |
| YIELD10 BIOSCIENCE, INC. | Process Industries |
| Bedrijven in privébezit | 3 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
